STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia Repair

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBispebjerg Hospital

About this trial

The five risky lifestyles Smoking, Nutrition (obesity and malnutrition), risky Alcohol intake, and Physical inactivity (SNAP) are common in surgical patients and associated with worse postoperative outcomes. Mono-factor interventions targeting and improving these risky lifestyles have been shown to reduce the risk at surgery, but there is a lack of systematic assessment of all five lifestyles of the patient before surgery and related optimization.

This study aims to evaluate the effect of intensive combined lifestyle interventions (the STRONG programme) compared with treatment as usual in patients undergoing ventral hernia repair on postoperative complications, health, and costs on short and longer term.

The hypothesis is that the STRONG programme will halve the complication rates within 30 days.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants ≥18 years scheduled for ventral hernia repair (defect smaller than 8cm)

Enough time for at least 4 weeks of prehabilitation

Screened positive for at least 1 risky SNAP factor

Signed informed consent

Disqualifiers

Ventral hernia repairs with defect larger than 8 cm

Pregnancy/breastfeeding

Allergy/other contradiction to pharmaceutical and/or nutritional support

Contradiction to exercise

Trial design

Design model

Parallel

Treatments tested in this trial

  • Prehabilitation (the STRONG programme)

    Behavioral

    Participants screened positive for one or more SNAP factors and randomised to the intervention group will receive an individualised plan for prehabilitation of their specific SNAP factors.

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: PrehabilitationExperimental treatment 1 intervention
Group B: Treatment as usualNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Postoperative complications within 30 days

Number and proportion of participants with at least one postoperative complication defined by requiring treatment

Time frame
30 days

Secondary outcomes

1

Postoperative complications within 3 and 6 months

Number and proportion of participants with at least one postoperative complication defined by requiring treatment

Time frame
3 months, 6 months
2

Comprehensive Complication Index (CCI)

Calculated from the Clavien-Dindo classification of the postoperative complications

Time frame
30 days, 3 months, 6 months
3

Successful quitting of risky lifestyles

Number and proportion of participants without all of their preoperative risky lifestyles (identified at baseline). Successful quitting of risky lifestyles are defined as: * Smoking: no use of any tobacco products * Malnutrition: not at risk of malnutrition defined as NRS \<3 * Obesity: 5-10 % loss of body fat mass compared to baseline * Alcohol: Zero alcohol intake at end of intervention/surgery and below risky limits (\<14 units per week) at postoperative follow-ups * Physical inactivity: being physically active at least 3.5 hours per week

Time frame
End of intervention/at surgery, 30 days, 3 months, 6 months
4

Any improvement of risky lifestyles

Number and proportion of participants with any improvement of any of their risky lifestyles compared with baseline. Any improvements include: * Smoking: a reduced number of cigarettes * Malnutrition: improvement in level of malnutrition (NRS scale) * Obesity: any loss of body fat mass * Alcohol: a reduced alcohol intake weekly (reduced number of units weekly) * Physical inactivity: Any improvement in minutes of daily physical activity

Time frame
End of intervention/at surgery, 30 days, 3 months, 6 months

Other outcomes

1

Postoperative length of stay

Descriptively reported as total time in hospital within 30 postoperative days with 95% CI

Time frame
From surgery until 30 days postoperative
2

Readmission

Descriptively reported as number and proportion (in %) of participants with readmission with 95% CI

Time frame
90 days
3

Time back to work/usual activities

Descriptively reported, patient reported

Time frame
30 days, 3 months, 6 months
4

Hernia recurrence

Descriptively reported as number and proportion of participants with hernia recurrence

Time frame
90 days

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Bispebjerg Hospital

Lead sponsor

Copenhagen University Hospital at Herlev

Collaborator

Zealand University Hospital

Collaborator

Holbaek Sygehus

Collaborator